A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).
文献类型：期刊论文
| 作者 | Li, Peijing; Chen, Yuan Yuan Yuan; Lai, Shuzhen; Jiang, Fagui; Liu, Xiaohui; Tao, Changjuan; Wang, Lei; Liu, Guihong; Huang, Jing; Tang, Yiqiang |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.2039 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000708120600324 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126698]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Kecheng Dist Peoples Hosp, Quzhou, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 3.Shantou Univ, Guangdong YueBei Peoples Hosp, Shaoguan, Peoples R China 4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 5.Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China 6.Nanjing Med Univ, Huaian Hosp 1, Huaian, Peoples R China 7.Nanchang Univ, Canc Hosp, Nanchang, Jiangxi, Peoples R China 8.Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China 9.Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China 10.Maoming Peoples Hosp, Maoming, Peoples R China |
| 推荐引用方式 GB/T 7714 | Li, Peijing,Chen, Yuan Yuan Yuan,Lai, Shuzhen,et al. A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Li, Peijing.,Chen, Yuan Yuan Yuan.,Lai, Shuzhen.,Jiang, Fagui.,Liu, Xiaohui.,...&Lu, Fangxiao.(2021).A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM)..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Li, Peijing,et al."A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。